SYM 0.00% $2.63 symbio holdings limited

appealing buying opportunity

  1. 45 Posts.
    Recent share price weakness overdone on fundamentals. Exceptional subscriber growth, negligble long term debt, solid product and appealing exposure to explosive emerging sector. Importantly, gross margin and ANRPU is excellent, and while underlying cash deficit is a short term concern, MNF would have little difficulty in securing a short term credit facility. With the velocity of subcriber growth increasing, look it MNF to become CF positive by mid year and with it a significant re-rating in market value.

    MNFO's offer superb leverage for price.
 
watchlist Created with Sketch. Add SYM (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.